Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Epidemiology of vancomycin-resistant enterococci in the United Arab Emirates

A retrospective analysis of 12 years of national AMR surveillance data

Bibliographic Data

ID22077495
AuthorsJens Thomsen (0000-0002-2646-9494, Khalifa University of Science and Technology, corresponding author), Najiba M Abdulrazzak (Dubai Hospital), Hussain AlRand (Ministry of Health), Godfred Antony Menezes (0000-0002-4102-2279, Ras al-Khaimah Medical and Health Sciences University), Carole Ayoub Moubareck (0000-0001-8369-5271, Zayed University), Dean Everett (0000-0002-8458-6779, Khalifa University of Science and Technology), Abiola Senok (0000-0001-6382-198X, Mohammed Bin Rashid University of Medicine and Health Sciences), Dean B Everett, Andreas Podbielski (Institute of Medical Microbiology and Hygiene)
Year2023
Volume11
Pages1275778-1275778
Publication date2023-11-27
Open AccessYes
TypeARTICLE
VenueFrontiers in Public Health (JOURNAL)
Journal identifiersISSN: 2296-2565 • E-ISSN: 2296-2565
PublisherFrontiers Media SA (PUBLISHER • CH)
DOI10.3389/fpubh.2023.1275778
PMID38089023
OpenAlexW4389053831
LanguageEN
References cited97

Introduction Enterococci are usually low pathogenic, but can cause invasive disease under certain circumstances, including urinary tract infections, bacteremia, endocarditis, and meningitis, and are associated with peritonitis and intra-abdominal abscesses. Increasing resistance of enterococci to glycopeptides and fluoroquinolones, and high-level resistance to aminoglycosides is a concern. National antimicrobial resistance (AMR) surveillance data for enterococci from the Middle East and North Africa (MENA) and the Gulf region is scarce. Methods A retrospective 12-year analysis of N = 37,909 non-duplicate diagnostic Enterococcus spp. isolates from the United Arab Emirates (UAE) was conducted. Data was generated by routine patient care during 2010–2021, collected by trained personnel and reported by participating surveillance sites to the UAE National AMR Surveillance program. Data analysis was conducted with WHONET. Results Enterococcus faecalis was the most commonly reported species (81.5%), followed by Enterococcus faecium (8.5%), and other enterococci species (4.8%). Phenotypically vancomycin-resistant enterococci (VRE) were found in 1.8% of Enterococcus spp. isolates. Prevalence of VRE (%VRE) was highest for E. faecium (8.1%), followed by E. faecalis (0.9%). A significant level of resistance to glycopeptides (%VRE) for these two species has been observed in the majority of observed years [ E. faecalis (0–2.2%), 2010: 0%, 2021: 0.6%] and E. faecium (0–14.2%, 2010: 0%, 2021: 5.8%). Resistance to fluoroquinolones was between 17 and 29% ( E. faecalis ) and was higher for E. faecium (between 42 and 83%). VRE were associated with higher patient mortality (RR: 2.97), admission to intensive care units (RR: 2.25), and increased length of stay (six excess inpatient days per VRE case), as compared to vancomycin-susceptible Enterococcus spp. Discussion Published data on Enterococcus infections, in particular VRE-infections, in the UAE and MENA region is scarce. Our data demonstrates that VRE-enterococci are relatively rare in the UAE, however showing an increasing resistance trend for several clinically important antibiotic classes, causing a concern for the treatment of serious infections caused by enterococci. This study also demonstrates that VRE were associated with higher mortality, increased intensive care unit admission rates, and longer hospitalization, thus poorer clinical outcome and higher associated costs in the UAE. We recommend the expansion of current surveillance techniques (e.g., local VRE screening), stricter infection prevention and control strategies, and better stewardship interventions. Further studies on the molecular epidemiology of enterococci are needed

Antibiotic resistance · Antibiotics · Bacteremia · Bacteria · Biology · Enterococcus · Enterococcus faecalis · Enterococcus faecium · Staphylococcus aureus · Vancomycin · Antimicrobial Resistance in Staphylococcus · Bacterial Identification and Susceptibility Testing · Medicine · Neonatal and Maternal Infections · Epidemiology · Internal Medicine · Microbiology

  • Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria

    Open Access•Anna-Pelagia Magiorakos, Arjun Srinivasan et al.•Clinical Microbiology and Infection•2012

  • Surveillance of antimicrobial resistance in the United Arab Emirates

    Open Access•Jens Thomsen, Najiba M Abdulrazzaq et al.•Frontiers in Public Health•2023

Highly citedNo

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae